Progression‐free survival and objective response rate as a surrogate end point for overall survival in metastatic renal cell carcinoma: A systematic review and meta‐analysis

Russell Leong, David Chen, Laith Almasri, Nicholas Lum, Karren Xiao, Maryam Soleimani, Christian K. Kollmannsberger, Srinivas Raman

Open source

DOI
10.1002/cncr.70616
Published
2026-09-24
Container
Cancer
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cncr.70616,
  title = {Progression‐free survival and objective response rate as a surrogate end point for overall survival in metastatic renal cell carcinoma: A systematic review and meta‐analysis},
  author = {Russell Leong and David Chen and Laith Almasri and Nicholas Lum and Karren Xiao and Maryam Soleimani and Christian K. Kollmannsberger and Srinivas Raman},
  year = {2026},
  journal = {Cancer},
  doi = {10.1002/cncr.70616},
  url = {https://doi.org/10.1002/cncr.70616}
}

RIS

TY  - JOUR
TI  - Progression‐free survival and objective response rate as a surrogate end point for overall survival in metastatic renal cell carcinoma: A systematic review and meta‐analysis
AU  - Russell Leong
AU  - David Chen
AU  - Laith Almasri
AU  - Nicholas Lum
AU  - Karren Xiao
AU  - Maryam Soleimani
AU  - Christian K. Kollmannsberger
AU  - Srinivas Raman
PY  - 2026
JO  - Cancer
DO  - 10.1002/cncr.70616
UR  - https://doi.org/10.1002/cncr.70616
ER  - 

APA

Leong, R., Chen, D., Almasri, L., Lum, N., Xiao, K., Soleimani, M., Kollmannsberger, C. K., & Raman, S. (2026). Progression‐free survival and objective response rate as a surrogate end point for overall survival in metastatic renal cell carcinoma: A systematic review and meta‐analysis. Cancer. https://doi.org/10.1002/cncr.70616

Source records